HomeCompareBFFTF vs BTI

BFFTF vs BTI: Dividend Comparison 2026

BFFTF yields 606.06% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BFFTF wins by $280371.13M in total portfolio value
10 years
BFFTF
BFFTF
● Live price
606.06%
Share price
$0.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$280371.17M
Annual income
$211,667,981,687.60
Full BFFTF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — BFFTF vs BTI

📍 BFFTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBFFTFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BFFTF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BFFTF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BFFTF
Annual income on $10K today (after 15% tax)
$51,515.15/yr
After 10yr DRIP, annual income (after tax)
$179,917,784,434.46/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, BFFTF beats the other by $179,917,782,065.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BFFTF + BTI for your $10,000?

BFFTF: 50%BTI: 50%
100% BTI50/50100% BFFTF
Portfolio after 10yr
$140185.60M
Annual income
$105,833,992,237.12/yr
Blended yield
75.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

BFFTF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-7.4
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BFFTF buys
0
BTI buys
0
No recent congressional trades found for BFFTF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBFFTFBTI
Forward yield606.06%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$280371.17M$37.7K
Annual income after 10y$211,667,981,687.60$2,786.64
Total dividends collected$274648.71M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: BFFTF vs BTI ($10,000, DRIP)

YearBFFTF PortfolioBFFTF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$71,306$60,606.06$11,299$598.92+$60.0KBFFTF
2$480,183$403,885.93$12,794$703.91+$467.4KBFFTF
3$3,055,680$2,541,883.57$14,518$829.07+$3.04MBFFTF
4$18,386,820$15,117,242.14$16,513$978.64+$18.37MBFFTF
5$104,687,331$85,013,433.96$18,827$1,157.84+$104.67MBFFTF
6$564,382,839$452,367,394.46$21,518$1,373.12+$564.36MBFFTF
7$2,883,114,581$2,279,224,943.60$24,657$1,632.46+$2883.09MBFFTF
8$13,966,501,456$10,881,568,854.67$28,329$1,945.74+$13966.47MBFFTF
9$64,208,586,900$49,264,430,341.75$32,637$2,325.33+$64208.55MBFFTF
10$280,371,169,670$211,667,981,687.60$37,708$2,786.64+$280371.13MBFFTF

BFFTF vs BTI: Complete Analysis 2026

BFFTFStock

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Full BFFTF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this BFFTF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BFFTF vs SCHDBFFTF vs JEPIBFFTF vs OBFFTF vs KOBFFTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.